In fact, CDK9 inhibition has been investigated as an anti-inflammatory therapeutic approach for inflammatory conditions, such as arthritis [75], since CDK9 inhibition was shown to increase the percentage of regulatory T cells in spleens from arthritic mice [75]. The gene discussed is CDK9; the disease is Arthritis.